Sherwin-Williams CoSHW
Price$320.78Intrinsic value$333.434% above price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $24.4B+5.7% YoYTTM through 30 Jun 2026
Net Income $2.7B+0.3% YoYTTM through 30 Jun 2026
Free Cash Flow $3.2BTTM through 30 Jun 2026

Margins

Current
Gross Margin49.0%
EBITDA Margin17.1%
Operating Margin14.3%
Net Margin11.0%

Returns

69.7%ROE
10.0%ROA
20.1%ROIC

Balance Sheet Health

Debt / Equity2.55x
Current Ratio0.73x
Net Debt$9.5B
Cash & Equivalents$293.5M

Quality Metrics

Altman Z-Score3.39
Piotroski F-Score7 / 9
FCF Margin13.2%
Rule of 4016.1
Earnings-Beat Rate75.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $23.6B
Diluted EPS$10.84TTM
'19'20'21'22'23'24'25
FY2025: $10.26

Dividend

$1.60Per share, FY20260.49%Yield-6.2%5-yr growth

Capital Allocation

Capex Intensity2.8%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.